MRI scans as test for prostate cancer to be trialled

Hundreds of men will be given MRI scans as part of a groundbreaking £5 million clinical trial into prostate cancer.

The trail, which starts in August, is pioneering a simple, 10-minute scan that scientists hope could provide the first reliable method for identifying dangerous tumours in the general population. Funded by the Medical Research Council and Cancer Research UK, the trial will invite 1,000 men aged 55 to 75 for scans through two London GP surgeries.

Unlike blood tests, the latest generation of scans appear to be effective at distinguishing between cancers that are likely to grow and spread and benign tumours that are safe to leave untreated.

Currently, screening for prostate cancer is not recommended in the UK because the available tests are too unreliable. However, the failure to detect prostate cancer early makes it difficult to treat and 11,000 men die from the disease in the UK each year.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho